Klea Holding SA (EPA:ALKLH)

Market Cap	48.44M -32.3%
Revenue (ttm)	19.34M -7.3%
Net Income	1.50M -39.7%
EPS	0.00 -36.0%
Shares Out	306.99M
PE Ratio	36.49
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	147,933
Open	0.1474
Previous Close	0.1564
Day's Range	0.1474 - 0.1578
52-Week Range	0.1040 - 0.2560
Beta	-0.49
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 18, 2026

About Klea Holding

Klea Holding SA, together with its subsidiaries, develops health technologies and services in France, the United Arab Emirates, and Saudi Arabia. It operates digitalized medical centers that provide administrative screenings for residency and work visas, preventive health check-ups, and medical fitness tests under the Smart Salem brand. In addition, the company engages in the production of pharmaceuticals. The company was formerly known as Visiomed Group SA and changed its name to Klea Holding SA in June 2024. Klea Holding SA was founded in 200...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2007
• Employees: 112
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALKLH

Financial Performance

In 2025, Klea Holding's revenue was 22.17 million, an increase of 28.42% compared to the previous year's 17.26 million. Earnings were 2.28 million, an increase of 62.35%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 6, 2026

Data Sources Report a data error